Idarucizumab - Open Access .click

Results 91 to 100 of about 2,468 (182)

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding

, 2017
Idarucizumab is licensed for emergency reversal of dabigatran. A single 5 g dose is usually sufficient, but higher doses may sometimes be required and optimum dosing has not been defined.
ten Cate, Hugo +14 more
core +1 more source

Idarucizumab in High-risk Thoracic Surgery

International Journal of Organ Transplantation Medicine, 2018
Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of ...
R L�pez Vilella +5 more
doaj

Anticoagulants: Updates on idarucizumab [PDF]

British Dental Journal, 2017
J S, Chandan, T, Thomas, H S, Baryah
openaire +2 more sources

Idarucizumab, il nuovo antidoto all'anticoagulante Dabigatran

, 2019
Dabigatran appartiene ad una nuova generazione di anticoagulanti orali approvati nel corso degli ultimi anni che offrono a medici e pazienti una più vasta gamma di opzioni per curare malattie tromboemboliche e per prevenire l’ictus nei pazienti con ...
HOLOVACH, VASYLYNA
core

Idarucizumab Dosing in Kidney Failure [PDF]